Pulse Biosciences (PLSE) Interest Expenses (2015 - 2026)
Pulse Biosciences (PLSE) posted quarterly Interest Expenses of $58.0 million for Q4 2025, up 2894.27% year-over-year from $1.9 million in Q4 2024, and up 504.85% quarter-over-quarter from $9.6 million in Q3 2025.
Pulse Biosciences (PLSE) Interest Expenses (2015 - 2026) Analysis & Trends
Pulse Biosciences' Interest Expenses history runs 11 years deep, the most recent figure standing at $58.0 million for Q4 2025.
- In Q4 2025, Interest Expenses rose 2894.27% year-over-year to $58.0 million; the TTM figure through Dec 2025 stood at $58.0 million (up 1777.35% YoY), while the FY2025 annual figure was $121.2 million, up 21.81% from the prior year.
- Interest Expenses for Q4 2025 stood at $58.0 million, up from $9.6 million in the prior quarter.
- The five-year high for Interest Expenses was $58.0 million in Q4 2025, with the low at $53000.0 in Q4 2021.
- The 5-year median for Interest Expenses is $1.1 million (2023), against an average of $4.7 million.
- The sharpest annual moves came in 2021 and 2025: Interest Expenses sank 96.26% in 2021, then jumped 2894.27% in 2025.
- Pulse Biosciences' Interest Expenses stood at $53000.0 in 2021, then surged by 2452.83% to $1.4 million in 2022, then dropped by 18.7% to $1.1 million in 2023, then soared by 76.18% to $1.9 million in 2024, then surged by 2894.27% to $58.0 million in 2025.
- Business Quant data shows PLSE's Interest Expenses at $58.0 million in Q4 2025, $9.6 million in Q3 2025, and $1.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 132.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 53.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.60 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 20.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 162.70 Mn |
| Jun 30, 2026 | 162.70 Mn |
| Dec 31, 2025 | 58.03 Mn |
| Dec 31, 2025 | 58.03 Mn |
| Sep 30, 2025 | 9.59 Mn |
| Sep 30, 2025 | 9.59 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 533,000.00 |
| Mar 31, 2025 | 533,000.00 |
| Dec 31, 2024 | 1.94 Mn |
| Dec 31, 2024 | 1.94 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 940,000.00 |
| Jun 30, 2024 | 940,000.00 |
| Mar 31, 2024 | 469,000.00 |
| Mar 31, 2024 | 469,000.00 |
| Dec 31, 2023 | 1.10 Mn |
| Dec 31, 2023 | 1.10 Mn |